| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffab7992ccae9685408a0f3ccf3c6bec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33250a839c3ebae0cee56975543c56c5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-168
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate |
2005-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_555e5cb299676bff05fb86c38dfe3740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5afd5d783fc916431cc67d8d0efae324 |
| publicationDate |
2006-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005115440-A3 |
| titleOfInvention |
Compositions and method for modulating insulin-activated nitric oxide synthase |
| abstract |
Compositions and methods are provided for increasing nitric oxide synthesis in cells or tissues through use of a non-insulin protein. The uses of the composition include treatment of cancer and diabetes mellitis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8591876-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403852-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9403851-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8282967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8981139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8956658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9526738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8962029-B2 |
| priorityDate |
2004-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |